Literature DB >> 17549284

The role of surgery in high-grade glioma--is surgical resection justified? A review of the current knowledge.

Boon-Chuan Pang1, Wei-Hwang Wan, Cheng-Kiang Lee, Kathleen Joy Khu, Wai-Hoe Ng.   

Abstract

INTRODUCTION: The aims of this article were to review the role of surgical resection in the management of high-grade gliomas and to determine whether there is any survival benefit from surgical resection.
METHODS: A literature review of the influence of surgical resection on outcome was carried out. Relevant original and review papers were obtained through a PubMed search using the following keywords: glioma, resection, prognosis and outcome.
RESULTS: Presently, there is a lack of evidence to support a survival benefit with aggressive glioma resection, but this should not detract patients from undergoing surgery as there are many other clinical benefits of glioma excision. In addition, limiting surgical morbidity through the use of adjuvant techniques such as intraoperative magnetic resonance imaging (MRI), functional MRI and awake craniotomy is becoming increasingly important.
CONCLUSIONS: Ideally, a randomised controlled trial would be the best way to resolve the issue of whether (and to what extent) surgical resection leads to improvements in patient outcome and survival, but this would not be ethical. The second best option would be well-controlled retrospective studies with a multivariate analysis of all potential confounding factors.

Entities:  

Mesh:

Year:  2007        PMID: 17549284

Source DB:  PubMed          Journal:  Ann Acad Med Singap        ISSN: 0304-4602            Impact factor:   2.473


  13 in total

1.  Comparing high-resolution microscopy techniques for potential intraoperative use in guiding low-grade glioma resections.

Authors:  Daphne Meza; Danni Wang; Yu Wang; Sabine Borwege; Nader Sanai; Jonathan T C Liu
Journal:  Lasers Surg Med       Date:  2015-04-14       Impact factor: 4.025

2.  Spectral and lifetime domain measurements of rat brain tumors.

Authors:  D Abi Haidar; B Leh; M Zanello; R Siebert
Journal:  Biomed Opt Express       Date:  2015-03-11       Impact factor: 3.732

3.  CpG ODN107 potentiates radiosensitivity of human glioma cells via TLR9-mediated NF-κB activation and NO production.

Authors:  Xiaoli Li; Dan Liu; Xin Liu; Weiwei Jiang; Weiying Zhou; Wei Yan; Yanyan Cen; Bin Li; Guanqun Cao; Guofu Ding; Xueli Pang; Jianguo Sun; Jiang Zheng; Hong Zhou
Journal:  Tumour Biol       Date:  2012-06-28

Review 4.  Clinical applications of imaging biomarkers. Part 2. The neurosurgeon's perspective.

Authors:  A Brodbelt
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

5.  Nimotuzumab in combination with radiotherapy in high grade glioma patients: a single institution experience.

Authors:  Maria Teresa Solomon; Nederlay Miranda; Eugenia Jorrín; Ivonne Chon; Jorge Juan Marinello; José Alert; Patricia Lorenzo-Luaces; Tania Crombet
Journal:  Cancer Biol Ther       Date:  2014-02-12       Impact factor: 4.742

6.  TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients.

Authors:  Chao Wang; Shouqiang Cao; Ying Yan; Qiao Ying; Tao Jiang; Ke Xu; Anhua Wu
Journal:  BMC Cancer       Date:  2010-08-10       Impact factor: 4.430

7.  The cytotoxic effect of β-elemene against malignant glioma is enhanced by base-excision repair inhibitor methoxyamine.

Authors:  Yongjian Zhu; Jue Hu; Fang Shen; Hong Shen; Weiguo Liu; Jianmin Zhang
Journal:  J Neurooncol       Date:  2013-05-23       Impact factor: 4.130

8.  Health-related quality of life in glioma patients in China.

Authors:  Jin-xiang Cheng; Bo-lin Liu; Xiang Zhang; Wei Lin; Yong-qiang Zhang; Wei-ping Liu; Jian-ning Zhang; Hong Lin; Rui Wang; Hong Yin
Journal:  BMC Cancer       Date:  2010-06-18       Impact factor: 4.430

9.  Perioperative outcomes following surgery for brain tumors: Objective assessment and risk factor evaluation.

Authors:  Aliasgar V Moiyadi; Prakash M Shetty
Journal:  J Neurosci Rural Pract       Date:  2012-01

10.  Intravenously administered alphavirus vector VA7 eradicates orthotopic human glioma xenografts in nude mice.

Authors:  Jari E Heikkilä; Markus J V Vähä-Koskela; Janne J Ruotsalainen; Miika W Martikainen; Marianne M Stanford; J Andrea McCart; John C Bell; Ari E Hinkkanen
Journal:  PLoS One       Date:  2010-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.